{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:47:35Z","timestamp":1787532455192,"version":"build-2736575974"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Critical Care"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.jcrc.2024.154533","type":"journal-article","created":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T17:57:06Z","timestamp":1707933426000},"page":"154533","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Immunologic effect and clinical impact of erythromycin in septic patients: A randomized clinical trial"],"prefix":"10.1016","volume":"81","author":[{"given":"Ahlem","family":"Trifi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Badis","family":"Tlili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Kallel Sellami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moncef","family":"Feki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asma","family":"Mehdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eya","family":"Seghir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynda","family":"Messaoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sami","family":"Abdellatif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salah","family":"Ben Lakhal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.jcrc.2024.154533_bb0005","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jcrc.2024.154533_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2022.156006","article-title":"Proinflammatory cytokines levels in sepsis and healthy volunteers, and tumor necrosis factor-alpha associated sepsis mortality: a systematic review and meta-analysis","volume":"158","author":"Gharamti","year":"2022","journal-title":"Cytokine"},{"issue":"11","key":"10.1016\/j.jcrc.2024.154533_bb0015","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1016\/j.immuni.2021.10.012","article-title":"The immunology of sepsis","volume":"54","author":"Van Der Poll","year":"2021","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.jcrc.2024.154533_bb0020","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/1523-1747.ep12610281","article-title":"Anti-inflammatory effects of antimicrobial agents: an in vivo study","volume":"65","author":"Plewig","year":"1975","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jcrc.2024.154533_bb0025","doi-asserted-by":"crossref","first-page":"302","DOI":"10.3389\/fimmu.2018.00302","article-title":"The immunomodulatory effects of macrolides-a systematic review of the underlying mechanisms","volume":"9","author":"Zimmermann","year":"2018","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.jcrc.2024.154533_bb0030","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/imr.12499","article-title":"The immune system\u2019s role in sepsis progression, resolution, and long-term outcome","volume":"274","author":"Delano","year":"2016","journal-title":"Immunol. Rev."},{"issue":"7","key":"10.1016\/j.jcrc.2024.154533_bb0035","doi-asserted-by":"crossref","first-page":"3819","DOI":"10.1128\/AAC.05798-11","article-title":"Effect of clarithromycin in inflammatory markers of patients with ventilator-associated pneumonia and sepsis caused by gram-negative bacteria: results from a randomized clinical study","volume":"56","author":"Spyridaki","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"issue":"4","key":"10.1016\/j.jcrc.2024.154533_bb0040","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1093\/jac\/dkt475","article-title":"Effect of clarithromycin in patients with suspected gram-negative sepsis: results of a randomized controlled trial","volume":"69","author":"Giamarellos-Bourboulis","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"issue":"1","key":"10.1016\/j.jcrc.2024.154533_bb0045","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s13054-022-04055-4","article-title":"Effect of intravenous clarithromycin in patients with sepsis, respiratory and multiple organ dysfunction syndrome: a randomized clinical trial","volume":"26","author":"Karakike","year":"2022","journal-title":"Crit. Care"},{"issue":"9","key":"10.1016\/j.jcrc.2024.154533_bb0050","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1056\/NEJMra1208623","article-title":"Severe sepsis and septic shock","volume":"369","author":"Angus","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jcrc.2024.154533_bb0055","series-title":"Statpearls [Internet]","article-title":"Macrolides","author":"Patel","year":"2023"},{"key":"10.1016\/j.jcrc.2024.154533_bb0060","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.3389\/fimmu.2018.01736","article-title":"Immune effects of corticosteroids in sepsis","volume":"9","author":"Heming","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jcrc.2024.154533_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.pupt.2021.102095","article-title":"The immunomodulatory effects of macrolide antibiotics in respiratory disease","volume":"71","author":"Pollock","year":"2021","journal-title":"Pulm. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.jcrc.2024.154533_bb0070","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.bbrc.2004.09.018","article-title":"The effect of long-term treatment with erythromycin on th1 and th2 cytokines in diffuse panbronchiolitis","volume":"324","author":"Park","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1\u20132","key":"10.1016\/j.jcrc.2024.154533_bb0075","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ejphar.2005.05.023","article-title":"Modulation of neutrophil and inflammation markers in chronic obstructive pulmonary disease by short-term azithromycin treatment","volume":"517","author":"Parnham","year":"2005","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.jcrc.2024.154533_bb0080","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/BF02852391","article-title":"Anti-inflammatory activity of clarithromycin in adults with chronically inflamed sinus mucosa","volume":"18","author":"Macleod","year":"2001","journal-title":"Adv. Ther."},{"issue":"4","key":"10.1016\/j.jcrc.2024.154533_bb0085","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S1081-1206(10)60935-0","article-title":"Effect of clarithromycin on cytokines and chemokines in children with an acute exacerbation of recurrent wheezing: a double-blind, randomized, placebo-controlled trial","volume":"97","author":"Fonseca-Aten","year":"2006","journal-title":"Ann. Allergy Asthma Immunol."},{"issue":"1","key":"10.1016\/j.jcrc.2024.154533_bb0090","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1365-2710.2006.00708.x","article-title":"Effects of claritromycin on inflammatory parameters and clinical conditions in children with bronchiectasis","volume":"31","author":"Yal\u00e7in","year":"2006","journal-title":"J. Clin. Pharm. Ther."},{"issue":"5","key":"10.1016\/j.jcrc.2024.154533_bb0095","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1378\/chest.12-0628","article-title":"Effect of azithromycin on systemic markers of inflammation in patients with cystic fibrosis uninfected with pseudomonas aeruginosa","volume":"142","author":"Ratjen","year":"2012","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.jcrc.2024.154533_bb0100","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s12890-023-02444-1","article-title":"The effect of azithromycin on sputum inflammatory markers in bronchiectasis","volume":"23","author":"Terpstra","year":"2023","journal-title":"BMC Pulm Med"},{"issue":"1","key":"10.1016\/j.jcrc.2024.154533_bb0105","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13027-023-00487-x","article-title":"Prophylactic treatment with oral azithromycin in cancer patients during the COVID-19 pandemic (ONCOVID): a randomized, single-blinded, placebo-controlled phase 2 trial","volume":"18","author":"Mair","year":"2023","journal-title":"Infect Agent Cancer"},{"issue":"4","key":"10.1016\/j.jcrc.2024.154533_bb0110","doi-asserted-by":"crossref","first-page":"299","DOI":"10.4046\/trd.2021.0075","article-title":"Efficacy and safety of azithromycin for the treatment of COVID-19: a systematic review and Meta-analysis","volume":"84","author":"Mangkuliguna","year":"2021","journal-title":"Tuberc. Respir. Dis."},{"key":"10.1016\/j.jcrc.2024.154533_bb0115","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s13546-012-0639-6","article-title":"Effets immunomodulateurs des macrolides au cours des pathologies respiratoires chroniques","volume":"22","author":"Guillon","year":"2013","journal-title":"R\u00e9animation"},{"issue":"1","key":"10.1016\/j.jcrc.2024.154533_bb0120","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1086\/315214","article-title":"Pro- versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options","volume":"181","author":"Gogos","year":"2000","journal-title":"J. Infect. Dis."},{"issue":"6","key":"10.1016\/j.jcrc.2024.154533_bb0125","first-page":"669","article-title":"Role of cytokines as a double-edged sword in sepsis","volume":"27","author":"Chaudhry","year":"2013","journal-title":"In Vivo"},{"issue":"4","key":"10.1016\/j.jcrc.2024.154533_bb0130","first-page":"216","article-title":"TNF-\u0391\/IL-10 ratio correlates with burn severity and may serve as a risk predictor of increased susceptibility to infections","volume":"5","author":"Tsurumi","year":"2016","journal-title":"Front. Public Health"}],"container-title":["Journal of Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883944124000200?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883944124000200?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T20:06:41Z","timestamp":1756757201000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0883944124000200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":26,"alternative-id":["S0883944124000200"],"URL":"https:\/\/doi.org\/10.1016\/j.jcrc.2024.154533","relation":{},"ISSN":["0883-9441"],"issn-type":[{"value":"0883-9441","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunologic effect and clinical impact of erythromycin in septic patients: A randomized clinical trial","name":"articletitle","label":"Article Title"},{"value":"Journal of Critical Care","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcrc.2024.154533","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"154533"}}